ABOUT US
-
Founded in 2021 by Dr. Ke Cheng, Xsome Biotech has licensed key IPs from North Carolina State University.
-
Xsome Biotech seeks to develop exosome therapeutics and novel drug delivery carriers for a variety of diseases.
-
The company's lead candidate, XO101, has gained IND approval for treating patients with ARDS.
Yujia JIng
VP, Business Development
SCIENTIFIC ADVISORY
Raghu Kalluri
M.D., Ph.D.
Chairman, Scientific Advisory Board of Xsome Biotech
Professor and Chairman, Department of Cancer Biology, University of Texas MD Anderson Cancer Center
Kenneth Adler Ph.D.
Processor of Cell Biology,
North Carolina State University
Jason Lobo M.D.
Director, UNC IPF Clinic;
Assistant Professor of Medicine, UNC School of Medicine
Thomas Caranasos M.D.
Director of Adult Cardiac Surgery and Assistant Professor of Surgery, UNC School of Medicine